Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) are nano- to micro-sized, lipid bilayer-enclosed particles secreted by mesenchymal stem cells (MSCs). These vesicles serve as mediators of intercellular communication and play a significant role in tissue regeneration, immunomodulation, and the delivery of bioactive molecules. They include exosomes, microvesicles, and apoptotic bodies, and carry proteins, lipids, mRNAs, miRNAs, and other non-coding RNAs. They interact with target cells through ligand-receptor interactions and internalization, modulating gene expression and cellular behavior. While showing promise in preclinical studies for various indications, clinical translation faces challenges in standardization, manufacturing, safety, and targeting.
Ligand-receptor interactions trigger downstream signaling; Internalization via receptor-mediated endocytosis or membrane fusion allows direct delivery of EV cargo into the cytoplasm, enabling functional transfer of mRNA/miRNA for protein synthesis or gene regulation within recipient cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenchymal Stem Cell-Derived Extracellular Vesicles (MSC-EVs).